IFN-γ can induce upregulation of HLA class I antigens in CRC cells, enhancing CRC antigen presentation to CD8+ cytotoxic T-lymphocytes, which, in turn, may eliminate CRC cells (Figure 1). The gene discussed is IFNG; the disease is colorectal carcinoma.